Carasent ASA (Norway) Today
| CARA Stock | 19.55 1.25 6.01% |
Performance5 of 100
| Odds Of DistressOver 63
|
Carasent ASA is selling for 19.55 as of the 29th of November 2024. This is a 6.01% down since the beginning of the trading day. The stock's lowest day price was 19.35. Carasent ASA has more than 63 % chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Carasent ASA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2024 and ending today, the 29th of November 2024. Click here to learn more.
Moving together with Carasent Stock
Moving against Carasent Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Carasent Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Carasent ASA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Carasent ASA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Information Services, Healthcare (View all Sectors) |
Carasent ASA (CARA) is traded on Oslo Stock Exchange in Norway and employs 153 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.33 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Carasent ASA's market, we take the total number of its shares issued and multiply it by Carasent ASA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Carasent ASA operates under Healthcare sector and is part of Health Information Services industry. The entity has 79.62 M outstanding shares.
Carasent ASA generates positive cash flow from operations, but has no cash available
Check Carasent ASA Probability Of Bankruptcy
Ownership AllocationCarasent ASA holds a total of 79.62 Million outstanding shares. 30% of Carasent ASA outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Carasent Ownership Details
Carasent ASA Risk Profiles
Although Carasent ASA's alpha and beta are two of the key measurements used to evaluate Carasent ASA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.64 | |||
| Semi Deviation | 1.87 | |||
| Standard Deviation | 2.19 | |||
| Variance | 4.8 |
Carasent Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Carasent ASA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Carasent ASA Corporate Management
Elected by the shareholders, the Carasent ASA's board of directors comprises two types of representatives: Carasent ASA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Carasent. The board's role is to monitor Carasent ASA's management team and ensure that shareholders' interests are well served. Carasent ASA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Carasent ASA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Johan Eltes | Chief Officer | Profile | |
| Daniel Ohman | Chief Officer | Profile | |
| Dennis Hojer | Chief Officer | Profile | |
| Advocate Schultz | Legal Counsel | Profile | |
| Chris Damvakaris | VP Devel | Profile | |
| Cornelia Broqvist | Chief Officer | Profile | |
| Niclas Hugosson | Founder,Chief Developer | Profile |
Other Information on Investing in Carasent Stock
Carasent ASA financial ratios help investors to determine whether Carasent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Carasent with respect to the benefits of owning Carasent ASA security.